RenovoRx (RNXT) Share-based Compensation (2020 - 2026)
RenovoRx's (RNXT) quarterly Share-based Compensation came in at $6.4 million in Q2 2026, up 72.59% year-over-year from $3.7 million in Q2 2025, and up 45.8% quarter-over-quarter from $4.4 million in Q1 2026.
Powered by 
Analysis
RenovoRx (RNXT) Share-based Compensation (2020 - 2026) Analysis & Trends
RenovoRx has disclosed Share-based Compensation across 7 years of filings, most recently posting $6.4 million for Q2 2026.
- In Q2 2026, Share-based Compensation rose 72.59% year-over-year to $6.4 million; the TTM figure through Jun 2026 stood at $6.4 million (up 72.59% YoY), while the FY2025 annual figure was $4.4 million, up 57.92% from the prior year.
- Share-based Compensation came in at $6.4 million for Q2 2026 at RenovoRx, up from $4.4 million in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $6.4 million in Q2 2026 to a low of $164000.0 in Q4 2022.
- Average Share-based Compensation over 5 years is $2.2 million, with a median of $1.8 million recorded in 2023.
- Year-over-year, Share-based Compensation surged 4499.3% in 2022 and gained 8.91% in 2025.
- Over 5 years, Share-based Compensation stood at $164000.0 in 2022, then jumped by 34.76% to $221000.0 in 2023, then gained by 14.03% to $252000.0 in 2024, then climbed by 13.1% to $285000.0 in 2025, then surged by 2162.89% to $6.4 million in 2026.
- Per Business Quant data, the three most recent Share-based Compensation figures were $6.4 million in Q2 2026, $4.4 million in Q1 2026, and $285000.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.53 Bn | 174.93 Bn | 7.27 Bn | 168.00 Mn |
| 2 | Intuitive Surgical | 127.82 Bn | 122.60 Bn | 1.96 Bn | 67.10 Mn |
| 3 | Medtronic | 117.07 Bn | 108.25 Bn | 6.34 Bn | 125.00 Mn |
| 4 | Stryker | 104.13 Bn | 100.65 Bn | 4.50 Bn | 7.00 Mn |
| 5 | Boston Scientific | 63.40 Bn | 62.86 Bn | 3.85 Bn | 61.00 Mn |
| 6 | Edwards Lifesciences | 49.72 Bn | 45.47 Bn | 1.35 Bn | 42.20 Mn |
| 7 | Alcon | 33.00 Bn | 31.55 Bn | 1.68 Bn | 42.00 Mn |
| 8 | Dexcom | 32.13 Bn | 30.18 Bn | 830.00 Mn | 39.00 Mn |
| 9 | Steris | 20.71 Bn | 20.23 Bn | 684.20 Mn | 12.80 Mn |
| 10 | RenovoRx | 83.67 Mn | 83.67 Mn | 766,000.00 | 6.45 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.45 Mn |
| Mar 31, 2026 | 4.42 Mn |
| Dec 31, 2025 | 285,000.00 |
| Sep 30, 2025 | 4.13 Mn |
| Jun 30, 2025 | 3.74 Mn |
| Mar 31, 2025 | 2.83 Mn |
| Dec 31, 2024 | 252,000.00 |
| Sep 30, 2024 | 2.72 Mn |
| Jun 30, 2024 | 2.65 Mn |
| Mar 31, 2024 | 2.60 Mn |
| Dec 31, 2023 | 221,000.00 |
| Sep 30, 2023 | 1.76 Mn |
| Jun 30, 2023 | 1.77 Mn |
| Mar 31, 2023 | 1.68 Mn |
| Dec 31, 2022 | 164,000.00 |
| Sep 30, 2022 | 1.20 Mn |
| Jun 30, 2022 | 919,861.00 |
| Mar 31, 2022 | 992,978.00 |
| Dec 31, 2021 | 126,000.00 |
| Sep 30, 2021 | 878,895.00 |